NDC product
SYRUP · Haleon US Holdings LLC
NDC 0031-8989 · Haleon US Holdings LLC
Key facts
| Product NDC | 0031-8989 |
|---|---|
| Nonproprietary name | acetaminophen, dextromethorphan HBr, doxylamine succinate |
| Substances | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE |
| Dosage form | SYRUP |
| Labeler | Haleon US Holdings LLC |
| Product type | DRUG FOR FURTHER PROCESSING |
| Marketing category | DRUG FOR FURTHER PROCESSING |
| Marketing start | Aug 21, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: